AAZTA5/AAZTA5-TOC : synthesis and radiochemical evaluation with 68Ga, 44Sc and 177Lu
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Erscheinungsjahr der gedruckten Ausgabe des Digitalisats: 2019
- Ereignis
-
Veröffentlichung
- (wo)
-
Mainz
- (wer)
-
Johannes Gutenberg-Universität Mainz
- (wann)
-
2019
- Urheber
- URN
-
urn:nbn:de:hebis:77-publ-593909
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sinnes, Jean-Philippe
- Nagel, Johannes
- Rösch, Frank
- Johannes Gutenberg-Universität Mainz
Entstanden
- 2019
Ähnliche Objekte (12)
![Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC](/assets/placeholder/searchResultMediaUnknown.png)
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Inter- and intra-tumoral heterogeneity on [68Ga]Ga-DOTA-TATE/[68Ga]Ga-DOTA-TOC PET/CT predicts response to [177Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients
TOC TOC TOC
Synthesis, radiolabeling and in vitro and in vivo evaluation of different chelator systems with 44Sc, 64Cu, 68Ga and 177Lu
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment
Occupational radiation exposure assessment during the management of [68Ga]Ga-DOTA-TOC
Optimization of 177Lu-labelling of DOTA-TOC, PSMA-I&T and FAPI-46 for clinical application
Instant kit preparation of 68Ga-radiopharmaceuticals via the hybrid chelator DATA : clinical translation of [68Ga]Ga-DATA-TOC
68Ga, 44Sc and 177Lu-labeled AAZTA5-PSMA-617: synthesis, radiolabeling, stability and cell binding compared to DOTA-PSMA-617 analogues
Microfluidic-based production of [68Ga]Ga-FAPI-46 and [68Ga]Ga-DOTA-TOC using the cassette-based iMiDEV™ microfluidic radiosynthesizer
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Inter- and intra-tumoral heterogeneity on [68Ga]Ga-DOTA-TATE/[68Ga]Ga-DOTA-TOC PET/CT predicts response to [177Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients
TOC TOC TOC
Synthesis, radiolabeling and in vitro and in vivo evaluation of different chelator systems with 44Sc, 64Cu, 68Ga and 177Lu
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment
Occupational radiation exposure assessment during the management of [68Ga]Ga-DOTA-TOC
Optimization of 177Lu-labelling of DOTA-TOC, PSMA-I&T and FAPI-46 for clinical application
Instant kit preparation of 68Ga-radiopharmaceuticals via the hybrid chelator DATA : clinical translation of [68Ga]Ga-DATA-TOC
68Ga, 44Sc and 177Lu-labeled AAZTA5-PSMA-617: synthesis, radiolabeling, stability and cell binding compared to DOTA-PSMA-617 analogues
Microfluidic-based production of [68Ga]Ga-FAPI-46 and [68Ga]Ga-DOTA-TOC using the cassette-based iMiDEV™ microfluidic radiosynthesizer
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Inter- and intra-tumoral heterogeneity on [68Ga]Ga-DOTA-TATE/[68Ga]Ga-DOTA-TOC PET/CT predicts response to [177Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients
TOC TOC TOC
Synthesis, radiolabeling and in vitro and in vivo evaluation of different chelator systems with 44Sc, 64Cu, 68Ga and 177Lu
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment
Occupational radiation exposure assessment during the management of [68Ga]Ga-DOTA-TOC
Optimization of 177Lu-labelling of DOTA-TOC, PSMA-I&T and FAPI-46 for clinical application
Instant kit preparation of 68Ga-radiopharmaceuticals via the hybrid chelator DATA : clinical translation of [68Ga]Ga-DATA-TOC
68Ga, 44Sc and 177Lu-labeled AAZTA5-PSMA-617: synthesis, radiolabeling, stability and cell binding compared to DOTA-PSMA-617 analogues